LMT
30
-2
FOX
51
-6
HST
39
-3
CB
57
2
A
37
-2
CA
22
-3
HRL
35
-3
HAS
30
-2
STT
64
2
DVN
14
-6
FMC
23
-3
AIZ
82
2
AEP
54
6
EL
15
-3
ORLY
60
-5
RRC
52
-6
SO
57
6
GT
56
-3
MTB
65
-2
CNX
73
-3
LMT
30
-2
FOX
51
-6
HST
39
-3
CB
57
2
A
37
-2
CA
22
-3
HRL
35
-3
HAS
30
-2
STT
64
2
DVN
14
-6
FMC
23
-3
AIZ
82
2
AEP
54
6
EL
15
-3
ORLY
60
-5
RRC
52
-6
SO
57
6
GT
56
-3
MTB
65
-2
CNX
73
-3
Financhill
Back

BNY Mellon International Equity ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
49

BKIE
BNY Mellon International Equity ETF

Last Price:
73.41
Seasonality Move:
5.63%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
49
BNY Mellon International Equity ETF (BKIE) is a Sell

Is BNY Mellon International Equity ETF a Buy, Sell or Hold?

  • The current BNY Mellon International Equity ETF [BKIE] share price is $73.48. The Score for BKIE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BKIE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKIE Stock Price Chart

What is BNY Mellon International Equity ETF's stock price today?

  • The BNY Mellon International Equity ETF share price today is $73.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKIE is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BKIE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.81 Sell
Relative Strength Index (14 RSI): 33.4 Sell
Chaikin Money Flow: -7604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.62 - 76.86) Sell
Bollinger Bands (100): (74.32 - 77.96) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BKIE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.68 Sell
20-day SMA: 75.35 Sell
50-day SMA: 76.84 Sell
200-day SMA: 75.08 Sell
8-day EMA: 74.43 Sell
20-day EMA: 75.3 Sell
50-day EMA: 76.09 Sell
200-day EMA: 74.61 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

BNY Mellon International Equity ETF Earnings Growth & BKIE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

BNY Mellon International Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):